Position in ELVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$343,914,074
+$31,900,185 QoQ
Shares Held
6,776,632
-14.9% QoQ
Ownership
9.25%
of shares outstanding
% of Portfolio
6.80%
of 13F equity value
Holder Rank
#2
of 208 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. ELVN ranks #2 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $630,516,329 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
This page
|
6,776,632 | $343,914,074 | |
| 3 | MBX |
MBX Biosciences, Inc.
|
3,428,736 | $189,266,227 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
2,209,400 | $118,578,498 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
2,555,877 | $112,433,029 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $107,045,189 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
3,027,328 | $105,169,374 | |
| 8 | ARGX |
Argenx SE
|
92,880 | $86,171,277 |
All Filings in ELVN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $343,914,074 | 6,776,632 | Shares | Sole | 2026-08-14 | |
| 2026-06-22 | $311,356,341 | 6,774,507 | Shares | Sole | 2026-06-24 | |
| 2026-06-15 | $323,402,926 | 7,634,630 | Shares | Sole | 2026-06-17 | |
| 2026-03-31 | $312,013,889 | 7,959,538 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $122,576,885 | 7,959,538 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $162,931,742 | 7,959,538 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $159,668,332 | 7,959,538 | Shares | Defined | 2025-08-14 | |
| 2025-06-16 | $182,830,383 | 7,918,163 | Shares | Sole | 2025-06-17 | |
| 2025-03-31 | $156,643,707 | 7,959,538 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $179,089,605 | 7,959,538 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $203,286,600 | 7,959,538 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $186,014,403 | 7,959,538 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $158,280,765 | 8,998,338 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $124,536,997 | 8,998,338 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $122,917,297 | 8,998,338 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $183,656,078 | 8,998,338 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $197,017,064 | 8,996,213 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||